Markus Schwaiger, MD, was named this year’s recipient of the Georg Charles de Hevesy Nuclear Pioneer Award at SNMMI's Annual Meeting.
Category: Nuclear Medicine
New research has confirmed the accuracy of the novel European Association of Urology (EAU) risk classification system that groups prostate cancer patients based on their risk of recurrence.Read More
By combining information from two advanced imaging techniques with clinical data, physicians can improve their prediction of heart attacks, according to research published in The Journal of Nuclear MedicineRead More
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and peer medical groups have issued appropriate use criteria for prostate-specific membrane antigen PET imaging.Read More
Johns Hopkins Medicine researchers have shown that PET scans can be used to “see” the movement of the drug rifampin in a living body, so that it can better treat bacterial infections attacking orthopedic implant-assisted bone.Read More
The Radiological Society of North America (RSNA) is teaming up with RadSite, an accreditation organization for advanced diagnostic imaging, to pilot the RSNA Quantitative Imaging Biomarkers Alliance Profile for fluorodeoxyglucose (FDG) PET/CT imaging.Read More